Tirzepatide 20mg / 40mg
Synthetic dual GIP / GLP-1 receptor agonist, lyophilised powder (≥98% purity) for laboratory research into metabolic signalling pathways.
- Peptide Type
- Dual GIP and GLP-1 receptor agonist analogue
- Form
- Lyophilised powder
- Quantity
- 20mg or 40mg
- Purity
- ≥98% (subject to batch testing)
- Appearance
- White lyophilised powder
- Solubility
- Water soluble
- Stability
- Maintains integrity under controlled storage conditions
- Manufacturing Standard
- Produced in controlled laboratory environments
Product Overview
Tirzepatide 20mg/40mg is a synthetic dual agonist peptide supplied as a lyophilised powder for laboratory research use. It is selected within controlled environments for investigation into peptide structure, receptor interaction, and signalling pathways.
Research Overview
Within laboratory settings, Tirzepatide is studied for its interaction with glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Research applications focus on receptor binding activity, peptide stability, and signalling pathways associated with metabolic regulation under controlled experimental conditions.
Handling & Use
This product is typically reconstituted using bacteriostatic water or a suitable sterile solvent within a controlled laboratory setting. All handling should be carried out by qualified professionals using appropriate sterile techniques and safety procedures.
Storage Guidelines
- Store in a cool, dry environment before reconstitution.
- For extended stability, storage at -20°C is recommended.
- Avoid repeated freeze-thaw cycles after reconstitution.
- This product is intended strictly for laboratory research purposes only.
- Not for human or veterinary use.
- Not intended to diagnose, treat, cure, or prevent any condition.
- This product must be handled by qualified professionals only.